The expression of SEMA3B by cancer cells has been shown to recruit tumor-associated macrophages (TAMs) into the tumor microenvironment by the activation of a neuropilin-mediated signaling pathway that leads to an autocrine release of IL-8 [23], thereby promoting cancer progression. The gene discussed is SEMA3B; the disease is cancer.